| Vasculitis and related conditions | Lifetime | 107 | FR 11 | 98.51 |
| Systemic Lupus Erythematosus Research | Lifetime | 659 | FR 34 | 98.11 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 70 | FR 7 | 97.80 |
| Renal Diseases and Glomerulopathies | Lifetime | 438 | FR 33 | 97.89 |
| Systemic Sclerosis and Related Diseases | Lifetime | 729 | FR 52 | 95.32 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 413 | FR 34 | 94.83 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 561 | FR 42 | 94.42 |
| Vascular Anomalies and Treatments | Lifetime | 235 | FR 32 | 94.53 |
| Eosinophilic Disorders and Syndromes | Lifetime | 932 | FR 81 | 94.01 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 356 | FR 10 | 90.42 |
| Lymphadenopathy Diagnosis and Analysis | Lifetime | 566 | FR 37 | 25.61 |
| Otitis Media and Relapsing Polychondritis | 2021-2025 | 3 | FR 2 | 99.34 |
| Vascular Anomalies and Treatments | 2021-2025 | 7 | FR 3 | 98.22 |
| Vasculitis and related conditions | 2021-2025 | 82 | FR 9 | 96.98 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 144 | FR 14 | 95.05 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 360 | FR 27 | 93.66 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 158 | FR 14 | 92.57 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 967 | FR 62 | 90.93 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 763 | FR 35 | 90.84 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 226 | FR 14 | 88.96 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 341 | FR 20 | 87.38 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 409 | FR 20 | 87.97 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 769 | FR 59 | 85.07 |
| Reproductive System and Pregnancy | 2021-2025 | 954 | FR 18 | 82.96 |
| Pregnancy and Medication Impact | 2021-2025 | 560 | FR 22 | 80.38 |
| Platelet Disorders and Treatments | 2021-2025 | 774 | FR 54 | 81.83 |
| Complement system in diseases | 2021-2025 | 653 | FR 65 | 75.08 |
| Urticaria and Related Conditions | 2021-2025 | 925 | FR 47 | 74.99 |
| Congenital Ear and Nasal Anomalies | 2021-2025 | 83 | FR 7 | 65.50 |
| Mast cells and histamine | 2021-2025 | 618 | FR 42 | 70.30 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 961 | FR 52 | 69.59 |
| Histiocytic Disorders and Treatments | 2021-2025 | 235 | FR 31 | 67.37 |
| Ectopic Pregnancy Diagnosis and Management | 2021-2025 | 995 | FR 30 | 56.52 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 935 | FR 74 | 54.34 |
| Skin Diseases and Diabetes | 2021-2025 | 520 | FR 25 | 49.18 |
